License Territory Expanded: ARVN001 for UME
source: pixabay.com

License Territory Expanded: ARVN001 for UME

When it comes to pharmaceuticals, licensed territory helps ensure that drugs within a certain territory are offered to patients. Exclusive licenses sometimes mean that pharmaceuticals are only available in specific…

Continue Reading License Territory Expanded: ARVN001 for UME
Study Shows Eculizumab can Improve Outcomes and Quality of Life for Paroxysmal Nocturnal Hemoglobinuria Patients
source: pixabay.com

Study Shows Eculizumab can Improve Outcomes and Quality of Life for Paroxysmal Nocturnal Hemoglobinuria Patients

Paroxysmal nocturnal hemoglobinuria (PNH) occurs from a mutated PIG-Agene. This causes blood cells to be produced which don't have surface proteins. As such, the cells aren't protected adequately from the complement…

Continue Reading Study Shows Eculizumab can Improve Outcomes and Quality of Life for Paroxysmal Nocturnal Hemoglobinuria Patients
Omadacycline for NTM Lung Disease Earns Orphan Drug Status
https://unsplash.com/photos/Y14ONzYtxb4

Omadacycline for NTM Lung Disease Earns Orphan Drug Status

In the United States, Orphan Drug designation is granted to drugs or biologics intended to treat patients with rare conditions, defined as affecting fewer than 200,000 Americans. As incentives, drug…

Continue Reading Omadacycline for NTM Lung Disease Earns Orphan Drug Status
Man with Albinism Killed in Malawi; Urgent Change and Protection Needed
Shared under Creative Commons license. Attributed to Richard Potts. https://www.flickr.com/photos/cascade_of_rant/5437953172

Man with Albinism Killed in Malawi; Urgent Change and Protection Needed

  On August 17, 2021, Amnesty International released an urgent call to action to provide protection in Malawi for those with albinism. This call for change came following the death…

Continue Reading Man with Albinism Killed in Malawi; Urgent Change and Protection Needed